Anticancer effect of rosiglitazone in rats treated with N-nitrosodiethylamine via inhibition of DNA synthesis: an implication for hepatocellular carcinoma. Issue 84 (16th September 2015)

• Record Type: Journal Article
• Authors: Anwar, Firoz; Mushtaq, Gohar; Kazmi, Imran; Afzal, Muhammad; Khan, Ruqaiyah; Al-Abbasi, Fahad A.; Ahmad, Aftab; Kumar, Vikas
• Is Part Of: RSC advances. Volume 5:Issue 84(2015)
• Page Start: 68385
• Page End: 68391
• Publication Date: 2015-09-16
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/c5ra07291c
• Languages: English
• ISSNs: 2046-2069

Abstract

<abstract abstract-type="toc"> <title> <x xml:space="preserve">Abstract</x> </title> <p> <graphic position="anchor" id="ga" xlink:href="ark:/27927/pgj2rw66v21" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" />Rosiglitazone, peroxisome proliferator-activated receptor-γ (PPARγ) ligand, is a clinically tested drug used in the treatment of diabetes.</p> </abstract>